WallStreetZenWallStreetZen

NASDAQ: QTRX
Quanterix Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for QTRX

Based on 2 analysts offering 12 month price targets for Quanterix Corp

Min Forecast
$3.00+0.33%
Avg Forecast
$3.00+0.33%
Max Forecast
$3.00+0.33%

Should I buy or sell QTRX stock?

Based on 2 analysts offering ratings for Quanterix Corp.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although QTRX's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates QTRX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their QTRX stock forecasts and price targets.

QTRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-17
lockedlocked$00.00+00.00%2026-08-11

1 of 1

Forecast return on equity

Is QTRX forecast to generate an efficient return?

Company
N/A
Industry
23.24%
Market
166.97%

Forecast return on assets

Is QTRX forecast to generate an efficient return on assets?

Company
N/A
Industry
13.76%

QTRX earnings per share forecast

What is QTRX's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.46
Avg 2 year Forecast
-$1.55
Avg 3 year Forecast
-$1.33

QTRX revenue forecast

What is QTRX's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$173.3M+12.99%
Avg 2 year Forecast
$192.4M+25.43%
Avg 3 year Forecast
$213.9M+39.43%
QTRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

QTRX revenue growth forecast

How is QTRX forecast to perform vs Medical Devices companies and vs the US market?

Company
11.65%
Industry
7.6%
Market
13.27%
QTRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
QTRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

QTRX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
QTRX$2.99$3.00+0.33%Hold
MXCT$1.38$5.00+262.32%Buy
INGN$5.61$12.00+113.90%Strong Buy
APYX$3.12$6.33+102.98%Strong Buy
LNSR$8.68$10.00+15.21%Strong Buy
View Top Medical Device Stocks

Quanterix Stock Forecast FAQ

Is Quanterix Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: QTRX) stock is to Hold QTRX stock.

Out of 2 analysts, 0 (0%) are recommending QTRX as a Strong Buy, 0 (0%) are recommending QTRX as a Buy, 2 (100%) are recommending QTRX as a Hold, 0 (0%) are recommending QTRX as a Sell, and 0 (0%) are recommending QTRX as a Strong Sell.

If you're new to stock investing, here's how to buy Quanterix stock.

What is QTRX's earnings growth forecast for 2026-2028?

(NASDAQ: QTRX) Quanterix's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.28%.

Quanterix's earnings in 2026 is -$123,109,000.On average, 5 Wall Street analysts forecast QTRX's earnings for 2026 to be -$68,981,665, with the lowest QTRX earnings forecast at -$75,545,942, and the highest QTRX earnings forecast at -$61,078,993. On average, 5 Wall Street analysts forecast QTRX's earnings for 2027 to be -$73,081,973, with the lowest QTRX earnings forecast at -$77,399,830, and the highest QTRX earnings forecast at -$67,534,497.

In 2028, QTRX is forecast to generate -$62,710,604 in earnings, with the lowest earnings forecast at -$72,765,110 and the highest earnings forecast at -$51,147,450.

What is QTRX's revenue growth forecast for 2026-2028?

(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 11.65% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.27%.

Quanterix's revenue in 2026 is $153,409,000.On average, 5 Wall Street analysts forecast QTRX's revenue for 2026 to be $8,197,306,956, with the lowest QTRX revenue forecast at $7,841,663,108, and the highest QTRX revenue forecast at $8,511,332,908. On average, 5 Wall Street analysts forecast QTRX's revenue for 2027 to be $9,100,131,567, with the lowest QTRX revenue forecast at $8,538,289,955, and the highest QTRX revenue forecast at $9,519,621,054.

In 2028, QTRX is forecast to generate $10,115,986,604 in revenue, with the lowest revenue forecast at $9,302,545,886 and the highest revenue forecast at $10,775,724,860.

What is QTRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: QTRX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.76%.

What is QTRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year QTRX price target, the average QTRX price target is $3.00, with the highest QTRX stock price forecast at $3.00 and the lowest QTRX stock price forecast at $3.00.

On average, Wall Street analysts predict that Quanterix's share price could reach $3.00 by Aug 17, 2027. The average Quanterix stock price prediction forecasts a potential upside of 0.33% from the current QTRX share price of $2.99.

What is QTRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: QTRX) Quanterix's current Earnings Per Share (EPS) is -$2.61. On average, analysts forecast that QTRX's EPS will be -$1.46 for 2026, with the lowest EPS forecast at -$1.60, and the highest EPS forecast at -$1.29. On average, analysts forecast that QTRX's EPS will be -$1.55 for 2027, with the lowest EPS forecast at -$1.64, and the highest EPS forecast at -$1.43. In 2028, QTRX's EPS is forecast to hit -$1.33 (min: -$1.54, max: -$1.08).

What is QTRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: QTRX) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.